Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.19.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Current Assets    
Cash $ 526,236
Prepaid expenses 140,141
Total Current Assets 666,377
Deferred offering costs 156,276
Marketable securities held in Trust Account 108,413,905
Total Assets 109,080,282 156,276
Current liabilities    
Account payable and accrued expenses 29,963 10,075
Accrued offering costs 43,700
Advance from related party 72,239
Promissory note - related party 34,259
Total Current Liabilities 29,963 160,273
Commitments
Ordinary shares subject to possible redemption, 10,365,307 shares at redemption value at March 31, 2019 104,050,316
Shareholders' Equity    
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Ordinary shares, $0.0001 par value; 100,000,000 shares authorized; 3,529,693 and 2,875,000 shares issued and outstanding (excluding 10,365,307 and -0- shares subject to possible redemption) at March 31, 2019 and December 31, 2018, respectively (1) 353 287 [1]
Additional paid-in capital 4,719,880 24,713
Retained earnings (Accumulated deficit) 279,770 (28,997)
Total Shareholders' Equity 5,000,003 (3,997)
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 109,080,282 $ 156,276
[1] As of December 31, 2018, this amount included an aggregate of 375,000 shares that were subject to forfeiture to the extent that the underwriters' over-allotment option was not exercised in full. As a result of the underwriters' election to partially exercise their over-allotment option in January 2019, an aggregate of 200,000 shares were no longer subject to forfeiture and 175,000 shares were subject to forfeiture to the extent that the underwriters' over-allotment was not exercised in full. The remaining over-allotment option expired unexercised on March 17, 2019 (see Note 7).